2nd Quarter - Report
BIOMET, INC. for BIOMET, INC.
Firm
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
PL 111-148 Medical device excise tax; Physician-owned distributorships (PODs); H.R. 436 Protect Medical Innovation Act; FDA 510(k) reform proposal; Medical Device User Fee and Modernization Act (MDUFMA); S.17-Medical Device Access and Innovation Act; H.R. 1700 - Medicare Patient Empowerment Act; H.R. 1249 - Leahy-Smith America Invents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM C KOLTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.